# Recovering From COVID-19 Lingering Symptoms Adaptive Integrative Medicine Trial - Effect of Hyperbaric Oxygen Therapy for the Treatment of Post COVID Condition

> **NCT06452095** · NA · RECRUITING · sponsor: **University Health Network, Toronto** · enrollment: 120 (estimated)

## Conditions studied

- Long COVID
- Post Acute Sequelae of COVID-19
- Post-COVID-19 Condition

## Interventions

- **DEVICE:** Hyperbaric Oxygen therapy

## Key facts

- **NCT ID:** NCT06452095
- **Lead sponsor:** University Health Network, Toronto
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2026-01-01
- **Primary completion:** 2029-12-31
- **Final completion:** 2029-12-31
- **Target enrollment:** 120 (ESTIMATED)
- **Last updated:** 2026-02-23


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06452095

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06452095, "Recovering From COVID-19 Lingering Symptoms Adaptive Integrative Medicine Trial - Effect of Hyperbaric Oxygen Therapy for the Treatment of Post COVID Condition". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT06452095. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*